Multiple sclerosis

Which drug is best for MS patients with no prior exposure to immunotherapy?

Dimethyl fumarate (Tecfidera) is more effective than teriflunomide (Aubagio) at preventing relapses in patients with relapsing remitting multiple sclerosis, data from a real-world study shows. In a population-based Danish MS Registry comparing the effectiveness of both therapies over ≈2 years in 2,236 patients with relapsing-remitting MS dimethyl fumarate showed a 42% lower relapse rate, with ...

Already a member?

Login to keep reading.

© 2021 the limbic